Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Martelli

Showing results (541-550 of 549) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 549 results.
Annals of Hematology|August 21, 2013
Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study)M Mian, D Capello, M B Ventre, et al.
Advances in Biological Regulation|May 4, 2019
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cellsShaw M Akula, Saverio Candido, Massimo Libra, et al.
Advances in Biological Regulation|March 23, 2019
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticalsSaverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Oncotarget|March 18, 2011
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human healthWilliam H Chappell, Linda S Steelman, Jacquelyn M Long, et al.
Oncotarget|July 23, 2014
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic interventionNicole M Davis, Melissa Sokolosky, Kristin Stadelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study GroupE Zucca, A Conconi, T I Mughal, et al.
Current Pharmaceutical Design|March 8, 2016
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for TherapyLinda S Steelman, Timothy Fitzgerald, Kvin Lertpiriyapong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2023
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive CellsMichele Simbolo, Nicola Silvestris, Giuseppe Malleo, et al.
Oncotarget|March 5, 2013
Advances in targeting signal transduction pathwaysJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Pageof 55

Showing results (541-550 of 549) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 549 results.
Annals of Hematology|August 21, 2013
Early-stage diffuse large B cell lymphoma of the head and neck: clinico-biological characterization and 18 year follow-up of 488 patients (IELSG 23 study)M Mian, D Capello, M B Ventre, et al.
Advances in Biological Regulation|May 4, 2019
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cellsShaw M Akula, Saverio Candido, Massimo Libra, et al.
Advances in Biological Regulation|March 23, 2019
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticalsSaverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Oncotarget|March 18, 2011
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human healthWilliam H Chappell, Linda S Steelman, Jacquelyn M Long, et al.
Oncotarget|July 23, 2014
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic interventionNicole M Davis, Melissa Sokolosky, Kristin Stadelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study GroupE Zucca, A Conconi, T I Mughal, et al.
Current Pharmaceutical Design|March 8, 2016
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for TherapyLinda S Steelman, Timothy Fitzgerald, Kvin Lertpiriyapong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2023
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive CellsMichele Simbolo, Nicola Silvestris, Giuseppe Malleo, et al.
Oncotarget|March 5, 2013
Advances in targeting signal transduction pathwaysJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Pageof 55